Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fate Therapeutics

1.60
+0.260019.40%
Post-market: 1.58-0.0180-1.13%19:58 EDT
Volume:4.68M
Turnover:7.27M
Market Cap:183.41M
PE:-1.07
High:1.68
Open:1.36
Low:1.36
Close:1.34
Loading ...
Aug 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 31, 2024

Major Issues Report

Form 8-K - Current report
Jun 10, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 10, 2024

Major Issues Report

Form 8-K - Current report
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 26, 2024

Correspondence

Form CORRESP - Correspondence
Mar 25, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 21, 2024

Major Issues Report

Form 8-K - Current report
Mar 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2024

Major Issues Report

Form 8-K - Current report
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 25, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals